1. "Body Imaging Service"
  2. "Sloan Kettering Institute Postdocs"
  3. "Cancer Research"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
Groups
  1. Body Imaging Service (8)
  2. GSK Faculty (8)
  3. Radiology, Department of (8)
  4. Sloan Kettering Institute Postdocs (8)
  5. Department of Medicine (6)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. Yingbei Chen (3)
  2. Abraham Hakimi (2)
  3. Emily Cheng (2)
  4. Larry Norton (2)
  5. Oguz Akin (2)
  6. Agnes Viale (1)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2019 (4)
  4. 2014 (1)
  5. 2013 (1)
Publications
  1. Cancer Research (8)
Publishers
  1. American Association for Cancer Research (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor immune microenvironment determinants of response to lenvatinib and a PD-1 blockade in clear cell renal cell carcinoma
    Meeting Abstract

    Vuong, L.; Kuo, F.; Jiang, H.; Mascareno, E. A.; Rappold, P.; Sabio, E.; Weiss, K.; Cornish, A.; Reese, S.; Adlesic, M.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • ARAF activates RAS by antagonizing its interaction with NF1
    Meeting Abstract

    Su, W.; Yaeger, R.; Na, N.; Hechtman, J.; Paroder, V.; Misale, S.; Han, S. W.; Abdel-Wahab, O. I.; McCormick, F.; Rosen, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The use of CT radiomics to predict immune infiltrate in pancreatic ductal adenocarcinoma
    Meeting Abstract

    McIntyre, C. A.; Chakraborty, J.; Koszalka, M.; Bassmann, J.; Chou, Y.; Gonen, M.; Allen, P. J.; Kingham, T. P.; D'Angelica, M. I.; Drebin, J. A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Hyperpolarized MRI visualizes Warburg effects and predicts treatment response to mTOR inhibitors in patient-derived ccRCC xenograft models
    Journal Article

    Dong, Y.; Eskandari, R.; Ray, C.; Granlund, K. L.; Dos Santos-Cunha, L.; Miloushev, V. Z.; Tee, S. S.; Jeong, S.; Aras, O.; Chen, Y. B.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Carrasquillo, J. A.; Danila, D. C.; Beylergil, V.; O'Donoghue, J. A.; Cheal, S. M.; Ruan, S. T.; Pandit-Taskar, N.; Fox, J. J.; Fleming, S. E.; Zanzonico, P. B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save